Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;24(8):409-25.
doi: 10.1097/FPC.0000000000000062.

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Ellen M McDonagh  1 , Sotiria Boukouvala, Eleni Aklillu, David W Hein, Russ B Altman, Teri E Klein
Affiliations
Review

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Ellen M McDonagh et al. Pharmacogenet Genomics. 2014 Aug.
No abstract available

PubMed Disclaimer

References

    1. International Union of Biochemistry and Molecular Biology (IUBMB) Nomenclature Committee Recommendations for Enzyme Nomenclature. 2013 Aug 13; http://www.chem.qmul.ac.uk/iubmb/enzyme/
    1. Hein DW. N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. Expert Opin Drug Metab Toxicol. 2009;5:353–366. - PMC - PubMed
    1. Stanley LA, Sim E. Update on the pharmacogenetics of NATs: structural considerations. Pharmacogenomics. 2008;9:1673–1693. - PubMed
    1. Sim E, Fakis G, Laurieri N, Boukouvala S. Arylamine N-acetyltransferases - from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention. Adv Pharmacol. 2012;63:169–205. - PubMed
    1. Sim E, Lack N, Wang CJ, Long H, Westwood I, Fullam E, Kawamura A. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms. Toxicology. 2008;254:170–183. - PubMed

Publication types